Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shaomei Li
Institution:
Second Hospital of Hebei Medical University
Observed institution:
Second Hospital of Hebei Medical University
ORCID:
0009-0008-8771-4386
Observed ORCID:
0009-0008-8771-4386
OpenAlex ID:
A5121341374
Efficacy and safety of obinutuzumab as rescue therapy for rituximab-resistant and rituximab-recurrent primary membranous nephropathy: a retrospective cohort study
2026
·
Li Tian
, Huaying Pei
, et al.
·
Open Medicine
·
1
Rituximab for refractory minimal change disease: Long-term outcomes in the remission maintenance phase
2025
·
Li Tian
, Lingling Xing
, et al.
·
Medicine
·
1
Combined and simultaneous use of Nefecon and irbesartan in treatment-naïve primary IgA nephropathy: A retrospective study
2026
·
Li Tian
, Huaying Pei
, et al.
·
Medicine
Cerebral venous sinus thrombosis secondary to relapsed minimal change disease: a case managed with endovascular thrombolysis
2026
·
Li Tian
, Hailong Du
, et al.
·
BMC Neurology
Show more works
View as search
Works count:
4
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type